Correlation Between Akero Therapeutics and Altamira Therapeutics
Can any of the company-specific risk be diversified away by investing in both Akero Therapeutics and Altamira Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akero Therapeutics and Altamira Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akero Therapeutics and Altamira Therapeutics, you can compare the effects of market volatilities on Akero Therapeutics and Altamira Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akero Therapeutics with a short position of Altamira Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akero Therapeutics and Altamira Therapeutics.
Diversification Opportunities for Akero Therapeutics and Altamira Therapeutics
-0.79 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Akero and Altamira is -0.79. Overlapping area represents the amount of risk that can be diversified away by holding Akero Therapeutics and Altamira Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Altamira Therapeutics and Akero Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akero Therapeutics are associated (or correlated) with Altamira Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Altamira Therapeutics has no effect on the direction of Akero Therapeutics i.e., Akero Therapeutics and Altamira Therapeutics go up and down completely randomly.
Pair Corralation between Akero Therapeutics and Altamira Therapeutics
Given the investment horizon of 90 days Akero Therapeutics is expected to generate 0.85 times more return on investment than Altamira Therapeutics. However, Akero Therapeutics is 1.18 times less risky than Altamira Therapeutics. It trades about 0.14 of its potential returns per unit of risk. Altamira Therapeutics is currently generating about -0.11 per unit of risk. If you would invest 2,971 in Akero Therapeutics on August 27, 2024 and sell it today you would earn a total of 302.00 from holding Akero Therapeutics or generate 10.16% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Akero Therapeutics vs. Altamira Therapeutics
Performance |
Timeline |
Akero Therapeutics |
Altamira Therapeutics |
Akero Therapeutics and Altamira Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Akero Therapeutics and Altamira Therapeutics
The main advantage of trading using opposite Akero Therapeutics and Altamira Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akero Therapeutics position performs unexpectedly, Altamira Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Altamira Therapeutics will offset losses from the drop in Altamira Therapeutics' long position.Akero Therapeutics vs. Eliem Therapeutics | Akero Therapeutics vs. HCW Biologics | Akero Therapeutics vs. Scpharmaceuticals | Akero Therapeutics vs. Milestone Pharmaceuticals |
Altamira Therapeutics vs. Eliem Therapeutics | Altamira Therapeutics vs. HCW Biologics | Altamira Therapeutics vs. Scpharmaceuticals | Altamira Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |